why choose us

300×250 Ad Slot

Research Article: BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country

Date Published: 2024-09-27

Abstract:
Introduction: Most pediatric low-grade-gliomas (LGG) and some high-grade-gliomas (HGG) have alterations in the RAS/MAPK pathway. Promising high tumor response rates were achieved using BRAF/MEK inhibitors, however data on their use in low-middle-income-countries (LMICs) are limited.

No summary available.

300×250 Ad Slot